V A Dudin

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Multiple Sclerosis

Disease Activity

Top Venues

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

This page only lists publications with an associated author ORCID identifier.

Publications

Alexey Boyko, K Z Bakhtiyarova, O V Boyko, V A Dudin, L G Zaslavsky, N A Malkova, Ye V Parshina, I Ye Poverennova, Stella Sivertseva, N A Totolyan, S G Shchur, F A Khabirov, Zoya A Goncharova, Maria Zakharova, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova, T V Chernovskaya, A A Porozova
[Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (2) (2023)
Alexey Boyko, K Z Bakhtiyarova, O V Boyko, V A Dudin, L G Zaslavsky, N A Malkova, Ye V Parshina, I Ye Poverennova, Stella Sivertseva, N A Totolyan, S G Shchur, F A Khabirov, Zoya A Goncharova, Maria Zakharova, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova, T V Chernovskaya, A A Porozova
[Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (2) (2023)
Alexey Boyko, O V Boyko, K Z Bakhtiyarova, E I Gusev, V A Dudin, L G Zaslavsky, N A Malkova, Ye V Parshina, I Ye Poverennova, Stella Sivertseva, N A Totolyan, S G Shchur, A S Fedulov, F A Khabirov, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova, T V Chernovskaya
[Efficacy and safety of sampeginterferon β-1a in the treatment of relapsing remitting multiple sclerosis: results of 52 weeks of therapy in a randomized, double-blind clinical trial]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 122 (1) (2022)